MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jjcc.2024.02.001

Медицинская библиотека · Journal of cardiology · 2024

Impact of postoperative hyperlactatemia in orthotopic heart transplantation.

Doi Atsuo, Batchelor Riley, Demase Kathryn C, Manfield Jaimi C, Burrell Aidan, Paul Eldho, Marasco Silvana F, Kaye David, McGiffin David C

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Hyperlactatemia (HL) is a common phenomenon after cardiac surgery which is related to tissue hypoperfusion and hypoxia and associated with poor outcomes. It is also often seen in the postoperative period after orthotopic heart transplantation (OHTx), but the association between HL and outcomes after OHTx is not well known. We evaluated the incidence and outcome of HL after OHTx.

METHODS

This was a retrospective study of 209 patients who underwent OHTx between January 2011 and December 2020. Patients were classified into 3 groups according to their peak lactate levels within the first 72 h postoperatively: group 1, normal to mild hyperlactatemia (<5 mmol/L, n = 42); group 2, moderate hyperlactatemia (5-10 mmol/L, n = 110); and group 3, severe hyperlactatemia (>10 mmol/L, n = 57). The primary composite endpoint was all-cause mortality or postoperative initiation of veno-arterial extracorporeal membrane oxygenation (VA ECMO) within 30 days. Secondary endpoints included duration of mechanical ventilation, intensive care unit length of stay, and hospital length of stay.

RESULTS

Patients with higher postoperative peak lactate levels were more commonly transplanted from left ventricular assist device support (33.3 % vs 50.9 % vs 64.9, p < 0.01) and had longer cardiopulmonary bypass time [127 min (109-148) vs 141 min (116-186) vs 153 min (127-182), p = 0.02]. Composite primary endpoint was met in 18 patients (8.6 %) and was significantly more common in patients with higher postoperative peak lactate levels (0.0 % vs 6.4 % vs 19.3 %, p < 0.01).

CONCLUSIONS

Severe hyperlactatemia following orthotopic heart transplant was associated with an increased risk of post-transplant VA ECMO initiation and mortality at 30 days.

Для цитирования: Doi Atsuo, Batchelor Riley, Demase Kathryn C, Manfield Jaimi C, Burrell Aidan, Paul Eldho, Marasco Silvana F, Kaye David, McGiffin David C. Impact of postoperative hyperlactatemia in orthotopic heart transplantation.. Journal of cardiology. 2024. DOI: 10.1016/j.jjcc.2024.02.001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.